Nutriband Stock

$7.54

6.57% yesterday

Nasdaq, Jul 29, 10:00 pm CET

ISIN

US67092M2089

Symbol

NTRB

Reports

Quarter | Annual

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Nutriband Stock price

$7.54

+1.37 22.18% 5Y

Nasdaq, Closing price Tue, Jul 29 2025

-0.53 6.57%

ISIN

US67092M2089

Symbol

NTRB

Reports

Quarter | Annual

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Key metrics

Basic

Market capitalization

$90.0m

Enterprise Value

$87.2m

Net debt

positive

Cash

$3.0m

Shares outstanding

11.1m

Valuation (TTM | estimate)

P/E

negative | negative

P/S

37.5 | 6.4

EV/Sales

36.4 | 6.2

EV/FCF

negative

P/B

17.7

Financial Health

Equity Ratio

86.1%

Return on Equity

-163.1%

ROCE

-195.0%

ROIC

Debt/Equity

0.0

Financials (TTM | estimate)

Revenue

$2.4m | $14.1m

EBITDA

$-9.9m | -

EBIT

$-10.2m | $-7.7m

Net Income

$-10.0m | $-6.4m

Free Cash Flow

$-5.2m

Growth (TTM | estimate)

Revenue

18.8% | 560.6%

EBITDA

-64.5% | -

EBIT

-61.6% | -14.7%

Net Income

-56.5% | 39.3%

Free Cash Flow

-42.2%

EPS

$-0.9

FCF per Share

$-0.5

Short interest

2.4%

Employees

Rev per Employee

$160.0k

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Get Started for Free Today

Nutriband Stock Analysis

Unlock Scores for Free

??

7 Analysts have issued a Nutriband forecast:

6x Buy

86%

More details on Analyst Estimates Including Price Targets

7 Analysts have issued a Nutriband forecast:

Buy

86%

Hold

14%

Analyst Estimates with Stock Price Targets

Financial data from Nutriband

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Apr '25		+/- %
Revenue	2.40 2.40	19% 19% 100%
- Direct Costs	1.57 1.57	30% 30% 65%
Gross Profit	0.83 0.83	4% 4% 35%
- Selling and Administrative Expenses	4.22 4.22	5% 5% 176%
- Research and Development Expense	2.83 2.83	12% 12% 118%
EBITDA	-9.90 -9.90	64% 64% -413%
- Depreciation and Amortization	0.27 0.27	4% 4% 11%
EBIT (Operating Income) EBIT	-10 -10	62% 62% -424%
Net Profit	-9.97 -9.97	57% 57% -415%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Nutriband Stock News

Neutral

GlobeNewsWire

●

12 days ago

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

ORLANDO, Fla., July 18, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) (“Nutriband” or the “Company”) is today reminding shareholders of the key dates associated with its upcoming 25% Preferred stock dividend.

Neutral

GlobeNewsWire

●

28 days ago

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

ORLANDO, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) (“Nutriband” or the “Company”) announced today that its Board of Directors has approved and declared a 25% preferred stock dividend.

Neutral

GlobeNewsWire

●

29 days ago

Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index

ORLANDO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), has been added as a member of the Russell Microcap, Russell Microcap Growth, Russell 3000E and Russell 3000E Growth Indexes, as part of the 2025 Russell indexes reconstitution.

More Nutriband News

Company Profile

Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It delivers abuse deterrent fentanyl transdermal system which provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. It operates through the Pocono Coated Products and Active Intelligence segments. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2016 and is headquartered in Orlando, FL.

Head office	United States
CEO	Gareth Sheridan
Employees	13
Founded	2012
Website	nutriband.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now